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In patients refractory to medical therapy, deep brain stimulations (DBSs) have emerged as the treatment of movement disorders
particularlyParkinson’sdisease.Theirusehasalsobeenextendedinpediatricandadultpatientstotreatepileptogenicfoci.Wehere
performed a retrospective chart review of anesthesia records from 28 pediatric cases of patients who underwent DBS implantation
for dystonia using combinations of dexmedetomidine and propofol-based anesthesia. Complications with anesthetic techniques
including airway and cardiovascular diﬃculties were analyzed.
1.Introduction
Dystonia is a movement disorder characterized by abnormal
repetitive and twisting movements resulting in painful and
debilitating postures [1]. Dystonia is termed primary when
it is idiopathic or may be secondary to a variety of diseases
including stroke, cerebral palsy, and neurodegenerative dis-
eases. The pathophysiology of dystonia is not well under-
stood though secondary dystonias often involve injury to the
globus pallidus (GP) [2], and electrophysiologic recordings
from GP pars interna (GPi) neurons of dystonic patients
show abnormal activity [3]. There is no medical cure for
dystonia. Medical therapy with anti-Parkinsonian, antispas-
modic, or anticholinergic drugs is targeted at symptomatic
relief but is only marginally eﬀective [4]. Surgical treatments
for dystonia traditionally involved lesioning thalamic nuclei
orthepallidum[5]andwereassociatedwithahighincidence
of complications, including hemiparesis and dysarthria [6].
With the advent of DBS, surgeons have turned to this new
surgical approach.
Deep brain stimulation (DBS) has emerged as the
treatment of choice for adult movement disorders that are
refractory to medical therapy. This includes DBS of the
subthalamic nucleus (STN) or GPi for Parkinson’s disease
(PD) [7, 8] and DBS of the ventrolateral thalamus for the
treatmentofessentialtremor[9].Asopposedtopallidotomy,
DBS is less destructive of brain tissue, is associated with
fewer cognitive and motor side eﬀects, and is reversible and
adjustable. Based on the evidence involving the GPi in the
pathophysiology of dystonia and based on clinical obser-
vations that pallidal DBS alleviates oﬀ-medication dystonia
in PD patients, the GPi has become the target of DBS for
dystoniapatientswithsigniﬁcantclinicalimprovements[10–
12].
The anesthetic challenges during DBS include providing
sedation and analgesia with minimal respiratory depression
or interference with electrophysiologic brain mapping and
clinical testing. Intraoperative cardiovascular hemodynam-
ics and blood pressure control are also important, as a
potential complication of DBS procedures is intracerebral
hemorrhage, which may occur in 2%–4% of cases [13]. The
α-2 agonist dexmedetomidine (Dex) is a unique anesthetic
agent which can provide sedation, analgesia, and decreased
arterial blood pressure without respiratory depression over
a broad range of doses, making it a potentially ideal sedative
forDBSsurgery[14].Thesepropertieshaveledtothecurrent
introduction of Dex-based anesthesia as an alternative to the
propofol/fentanyl anesthetic technique in PD patients who
require intraoperative sedation [15].
Dex has also recently been reported for use in pediatric
patients during neurosurgery [16, 17]. Here we present a
retrospective study of the use of Dex and propofol anesthesia
during DBS surgery in 28 pediatric cases from dystonia
patients ranging from 7 to 17 years of age.2 Anesthesiology Research and Practice
Table 1: Clinical characteristics of dystonia patients undergoing
deep brain stimulation. SD: standard deviation.
Characteristics Mean +/−SD Range
Age 12.2 +/− 2.6 7–17
Sex (men/women ratio) 18/10 n/a
Weight (kg) 42.8 +/− 13.4 26.0–86.4
Length of anesthesia (min) 297.4 +/− 69.5 125–434
Length of surgery (min) 167.2 +/− 57.5 65–313
2.MaterialsandMethods
After obtaining IRB approval, the anesthetic records from 28
pediatric DBS cases were reviewed. The following technique
was used.
In the preoperative holding area, patients received local
anesthesia (lidocaine plus bupivacaine) for placement of the
stereotacticheadframe(LeksellModelG,ElektaInc,Atlanta,
GA), supplemented with fentanyl and propofol boluses
as needed. Patients received propofol infusions for the
subsequent localizing MRI. Once the MRI was completed,
patients were brought to the OR, where standard anesthesia
monitoring (noninvasive arterial blood pressure cuﬀ, pulse
oximetry, electrocardiogram, and bispectral index monitor
(BIS)) was applied.
Sedation was continued with propofol and maintained
with propofol infusions plus small boluses of fentanyl as
needed until scalp incision. Local anesthesia, consisting
of 0.5% bupivacaine, was injected into the supraorbital
and greater occipital nerves to produce a “scalp block”.
Sedation was maintained during scalp incision and burr-
hole placement and until the time of intraoperative testing,
using a combination of Dex infusion (0.2 to 0.9μg/kg/hr)
and propofol boluses and/or infusions (rates of 15–
100μg/kg/min). BIS monitoring was used with target values
>70. Following intraoperative testing, small doses of fentanyl
and/or midazolam were administered as needed for discom-
fort. Following surgery, each patient underwent a second
MRI to check electrode placement with anesthesia provided
by propofol infusion.
Our pediatric patients ranged from 7 to 17 years of age,
and included both males and females suﬀering from pri-
mary or secondary dystonia. Demographic data and clinical
characteristicsaresummarizedinTable 1. Anesthetic records
from these patients were analyzed for medications used
during surgery and potential intraoperative complications.
3. Results
Our analysis is comprised of 28 consecutive cases of pallidal
DBS surgery for dystonia in pediatric patients. Table 2
summarizesthemedicationsgivenintraoperativelyincluding
both the average dose and range. The table displays the data
for the entire procedure (MRI plus procedure) and also for
the implant procedure alone. Indeed, this table describes the
relative use and dose of each anesthetic agent (as bolus or
infusion) during intraoperative DBS and compares it to the
values used during the entire case. Propofol was used in 27
cases for the entire procedure with an average total dose of
258.6mg, while it was used in 24 of the cases during the DBS
part of the procedure with an average total dose of 115.2mg.
A scalp block was performed in 7 cases.
Table 3 displays the surgical complications in our cases.
No airway diﬃculty, respiratory depression, hypoxemia, or
unplannedconversiontogeneralanesthesiawasencountered
in any of the cases. In addition, no seizures occurred,
and patients remained calm during the entirety of the
surgery. One patient suﬀered a venous air embolus following
burr-hole placement. The patient started to cough and
complained of chest pain. The head was lowered and bone
wax applied. The patient improved but the procedure was
aborted. One month later, he underwent successful DBS
surgery. Our rate of venous embolism (1 out of 28 cases or
3.6%) is very similar to the rate reported in the literature
for DBS surgeries [18]. Venous emboli are a known potential
complication of DBS, and although rare, they should always
be considered when the patient begins to cough suddenly
during the operative phase [18].
4. Discussion
We here describe a retrospective study examining anesthetics
used for DBS surgery in pediatric dystonia patients. As
previously mentioned, awake neurosurgery presents unique
anesthetic challenges. Diﬀerent techniques have been devel-
oped to meet this challenge, with propofol infusion alone
or in combination with fentanyl/remifentanil the method
most frequently reported [19, 20]. However, the use of these
anesthetic techniques may be accompanied by complications
such as airway obstruction, deep sedation, and respiratory
depression [21, 22].
Dex is a central α-2 adrenergic stimulant and is known
to have dose-reducing eﬀects when used with inhalational
anesthetics and opiates [23]. Dex oﬀers some unique anes-
thetic characteristics as it provides sedation and analgesia
while minimizing respiratory depression even at large doses
[24]. Therefore, Dex is ideally suited for the “asleep-awake-
asleep” technique often required for awake craniotomy [25].
With this technique, patients are anesthetized or sedated for
the initial craniotomy then allowed to wake up to participate
in neurocognitive mapping, and the original anesthesia or
sedation is resumed for the ﬁnal part of the procedure
[17, 25]. Sedation with Dex leaves a patient sleepy but
still arousable to an alert state, which is very useful for
intraoperative recording [25].
The anesthetic challenges during DBS surgery are to
alleviate the stress of awake neurosurgery without interfering
with neurophysiological monitoring or inducing respiratory
depression. We therefore employed a similar “asleep-awake-
asleep” anesthesia technique for pediatric dystonia patients
using a combination of propofol and Dex-based anesthesia.
In this way, anesthesia was performed with a high degree
of safety and minimal side eﬀects or intraoperative com-
plications. All patients tolerated the procedure well and
appeared comfortable. BIS monitoring helped in guiding theAnesthesiology Research and Practice 3
Table 2: Administered medications. The ﬁrst two columns display the number (#) of cases and doses of medications (Dex:
Dexmedetomidine) given during the entire procedure (MRIs + DBS), while the last two columns display these values for the intraoperative
DBS part of the procedure (DBS only).
Medications # cases Dose # cases Dose
Dose (MRIs + DBS) (MRIs + DBS) (DBS only) (DBS only)
Propofol infusion given 11 n/a 7 n/a
Dex infusion given 14 n/a 14 n/a
Scalp block performed 7 n/a 7 n/a
Propofol (total, mg) 27 258.6 +/− 189.0 (40–673.5) 24 115.2 +/− 91.3 (26.7–271.7)
Dex (μg) 14 36.7 +/− 30.4 (1.9–115.2) 14 33.9 +/− 23.8 (1.9–77.6)
Fentanyl (total, μg) 18 113.6 +/− 102.9 (10–450) 15 37.7 +/− 24.4 (12.5–100)
Midazolam (mg) 15 2.1 +/− 1.8 (0.5–8.0) 6 0.6 +/− 0.2 (0.5–1.0)
Plasmalyte-A (mL) 24 954.2 +/− 581.4 (250–2500) n/a n/a
Table 3: Intraoperative complications. Intraoperative complica-
tions are shown. For all the 28 cases, the only intraoperative
complication was a venous air embolism in one patient.
Intraoperative complication All cases
Airway diﬃculty 0 (28)
Respiratory depression 0 (28)
Desaturation/hypoxemia 0 (28)
Bradycardia 0 (28)
Agitation 0 (28)
Conversion to gen. anesthesia 0 (28)
Seizures 0 (28)
Venous Air embolism 1 (28)
anesthetic need with a target of 70–90 for the “awake” part of
the surgery.
Seven of the patients received a “scalp block”, which
provides regional anesthesia to the nerves of the scalp and
may include the supraorbital, supratrochlear, greater, and
lesser occipital nerves, the auriculotemporal nerves, and the
greater auricular nerves. Inﬁltration of these nerves with the
local anesthetic bupivacaine blunts hemodynamic responses
during craniotomy in both adult [26] and pediatric patients
[27]. Although quantiﬁcation of postoperative pain was not
available in the studied anesthetic records, scalp blocks using
the local anesthetic ropivacaine have previously been shown
todecreasepainseverityfollowingcraniotomyinadults[28].
Dex and propofol have been used successfully in DBS
for adult patients suﬀering from PD [15] and in both
pediatric and adult patients undergoing awake craniotomy
for epileptogenic focus resection [29]. Similarly, we here
report that the use of propofol in conjunction with Dex
duringDBSforpediatricdystoniapatientsissafe,eﬃcacious,
and well tolerated. The advantages of propofol include
both rapid onset of anesthesia and rapid awakening. It is
also important to allow patients to interact during DBS
as provided by Dex, with sedation coupled with minimal
respiratory depression. This enables clinicians to bond with
patients, reducing anxiety and fear, to assess eﬃcacy of DBS
testing,andtodetectanysideeﬀectsfromstimulationinreal-
time.
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